Literature DB >> 16426985

OSMS is NMO, but not MS: proven clinically and pathologically.

Brian G Weinshenker, Dean M Wingerchuk, Ichiro Nakashima, Kazuo Fujihara, Vanda A Lennon.   

Abstract

Mesh：

Substances：

Year:  2006        PMID： 16426985     DOI： 10.1016/S1474-4422(06)70333-7

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN： 1474-4422            Impact factor:   44.182


× No keyword cloud information.
  11 in total

Review 1.  A differential diagnosis of central nervous system demyelination: beyond multiple sclerosis.

Authors:  Christopher Eckstein; Shiv Saidha; Michael Levy
Journal:  J Neurol       Date:  2011-09-20       Impact factor: 4.849

Review 2.  [From neuromyelitis optica to neuromyelitis optica spectrum disorder: from clinical syndrome to diagnistic classification].

Authors:  Orhan Aktas; Tania Kümpfel
Journal:  Nervenarzt       Date:  2021-03-16       Impact factor: 1.214

3.  Treatment of neuromyelitis optica: current debate.

Authors:  Tomoko Okamoto; Masafumi Ogawa; Youwei Lin; Miho Murata; Sachiko Miyake; Takashi Yamamura
Journal:  Ther Adv Neurol Disord       Date:  2008-07       Impact factor: 6.570

4.  AQP4 antibody-positive Thai cases: clinical features and diagnostic problems.

Authors:  S Siritho; I Nakashima; T Takahashi; K Fujihara; N Prayoonwiwat
Journal:  Neurology       Date:  2011-08-03       Impact factor: 9.910

Review 5.  Update on neuromyelitis optica: natural history and management.

Authors:  Panitha Jindahra; T Plant
Journal:  Eye Brain       Date:  2012-03-26

Review 6.  AQP4 antibodies in neuromyelitis optica: diagnostic and pathogenetic relevance.

Authors:  Sven Jarius; Brigitte Wildemann
Journal:  Nat Rev Neurol       Date:  2010-07       Impact factor: 42.937

Review 7.  [Neuromyelitis optica].

Authors:  S Jarius; B Wildemann
Journal:  Nervenarzt       Date:  2007-12       Impact factor: 1.214

8.  Polymorphisms in the neuromyelitis optica auto-antigen AQP4 and susceptibility to multiple sclerosis.

Authors:  Maria Ban; Amie Walton; An Goris; Julia Gray; Alastair Compston; Stephen Sawcer
Journal:  J Neurol       Date:  2007-03-07       Impact factor: 4.849

9.  CD58 polymorphisms associated with the risk of neuromyelitis optica in a Korean population.

Authors:  Jason Yongha Kim; Joon Seol Bae; Ho Jin Kim; Hyoung Doo Shin
Journal:  BMC Neurol       Date:  2014-03-24       Impact factor: 2.474

10.  Diffuse white matter damage is absent in neuromyelitis optica.

Authors:  F Aboul-Enein; M Krssák; R Höftberger; D Prayer; W Kristoferitsch
Journal:  AJNR Am J Neuroradiol       Date:  2009-09-12       Impact factor: 4.966
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.